• On sale!
  • Out-of-Stock
search

Vicks Cough Fluidifier 200 MG/15 ML 180 ml bottle

  • Procter & Gamble S.r.l.
  • 028689026
Features:



Indicated in case of a fat and productive cough.



Contributes to the removal of mucus.



Deductible over-the-counter drug.



Indicated from two years of age



















info_outline View product sheet
Final Price €9.20
error Out-of-Stock

Notify me when available

  Convenient and safe payments

Even with a credit card

  Shipping in 24h all over the world

Fast and safe international shipping worldwide

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service. Experts in international shipping

Cough suppressants Others products at unbeatable price

Procter & Gamble S.r.l.

Discover all products

VICKS COUGH LIQUIDIFYER 200 MG/15 ML SYRUP

Therapeutic indications

Fluidifying in acute and chronic affections of the bronchial system.

Dosage and method of use

Adults and children over 12 years 15 ml (equivalent to 3 coffee spoons) Children from 6 to 11 years 10 ml (equivalent to 2 coffee spoons) Children from 2 to 5 years 5 ml (equivalent to 1 coffee spoon) These doses can be repeated every 4 hours, up to 6 times a day. DO NOT EXCEED THE RECOMMENDED DOSE.

Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.

Side effects

Allergic manifestations with itching, redness and erythema may be found in subjects hypersensitive to the components. Gastrointestinal disorders which may include symptoms such as: nausea, vomiting and diarrhea may rarely occur with guaifenesin. Reporting of suspected adverse reactions Reporting of suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system reported on the website: http://www.agenziafarmaco.gov.it/it/responsabili of the Italian Medicines Agency.

Special warnings

In case of determination of 5-hydroxy-indole-acetic acid and vanillylmandelic acid, guaifenesin may cause a false positive result. Do not administer to children under two years of age, unless advised by a doctor. The product contains sucrose, this should be taken into account in case of diabetes or low-calorie diets. Patients with chronic or persistent cough, such as that which occurs due to asthma, smoking, chronic bronchitis and emphysema should contact their doctor before taking this medicine. If symptoms persist for more than 7 days, consult your doctor. After a short period of treatment without appreciable results, consult your doctor. Important information about some of the excipients of VICKS COUGH FLUIDIFYER VICKS COUGH FLUIDIFYER contains sucrose: patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. VICKS COUGH FLUIDIFYER contains 30 mg of sodium in 15 ml. This information should be taken into consideration by patients undergoing a low sodium diet. VICKS COUGH FLUIDIFYER contains 5 vol% ethanol (alcohol), which corresponds to 640 mg per 15 ml of medicine, equivalent to 15 ml of beer or 6.3 ml of wine. It can be harmful to those suffering from alcoholism. This information is to be taken into consideration by pregnant or breastfeeding people, children and people at high risk such as those with liver failure or epilepsy.

Pregnancy and breastfeeding

The safety of guaifenesin during pregnancy and breastfeeding has not been fully established. ''During pregnancy or breastfeeding the product should only be used on the advice of your doctor.

Expiration and conservation

Store at a temperature not exceeding 25°C.

Interactions with other drugs

No interaction studies have been performed.

Overdose

Absorbed guaifenesin is rapidly metabolised and excreted in the urine. Treatment of overdose involves addressing specific symptoms. A mild or moderate overdose may cause confusion or dizziness and gastrointestinal upset. Very high doses can produce symptoms such as excitation, confusion and respiratory depression, nausea and vomiting. Treatment should be symptomatic, requiring gastric lavage and general supportive treatments. Rare cases of kidney or urinary stones have been reported in patients who have taken large amounts of guaifenesin for long periods of time.

Active principles

ACTIVE PRINCIPLE: Guaifenesin 1.333% w/v EXCIPIENTS: sucrose, ethanol, sodium For the complete list of excipients, see section 6.1

Excipients

EXCIPIENTS: Sucrose, Sodium saccharin, Propylene glycol, Ethanol (96%), Sodium citrate, Anhydrous citric acid, Sodium carmellose, Polyethylene oxide, Honey/ginger flavor 198628, Verbena flavor PHL 145439, Levomenthol, Macrogol-stearate, Sodium benzoate ( E211), Purified water.

028689026

Data sheet

Packaging
200 mg / 15 ml syrup 180 ml
Product Type
HUMAN DRUG
ATC code
R05CA03
ATC description
Guaifenesin
Therapeutic Group
Expectorants
Active principle
guaifenesin (DC.IT) (FU)
Class
C.
Pharmaceutical form
syrup
Type of Administration
oral
Container
bottle
Quantity
1 vial / vial / vial
Capacity
180 milliliters
Quantity of the Active Ingredient
1.33MG
Recipe required
OTC - self-medication medicine
chat Comments (0)